Stocks
Intelligent OutlookLLY-
Intelligent Outlook
LLY-
Prev Close-
50D MA-
200D MA-
52W High-
Live Price
LLY 24H Rolling
0.000.00%0.00
Rolling: Last 24h | 5m
LLY
Asset Information
Company Profile
Company:LLY
Sector:Pharmaceuticals
Industry:Pharmaceuticals
Country:US
Employees:47,000
IPO Date:1970-07-09
Website:www.lilly.com/
Technicals & Growth
Market Cap:$759.51B
Shares O/S:899,356,626
52W High:$935.63
52W Low:$623.78
50D MA:$774.65
200D MA:$787.82
Financial Ratios
P/E Ratio:55.23
EPS:$15.29
Profit Margin:31.67%
ROE (TTM):77.78%
ROA (TTM):18.35%
Div. Per Share:$6.00
LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Loading chart library...
Financial Data (Macrotrends)
Historical Data
Loading...